In this sense, SOCE/STIM2 prime the glucose metabolism of T cells that competes with its neighbor tumor cells, and the abnormalities of STIM2 or its downstream will render immune suppression resulting from T dysfunction. This evidence concerns the gene STIM2 and neoplasm.